Reproductive Health Planning for Patients with Multiple Sclerosis: A Clinician’s Guide

Target AudienceThis activity is designed to meet the educational needs of physicians, nurses and nurse midwives, advanced practice clinicians, and pharmacists, who manage patients with multiple sclerosis (MS). Program DescriptionMultiple sclerosis (MS) has a female predominance of approximately 3 to 1 and appears to be increasing among young women who are of reproductive age at […]

Advanced Perspectives in MS: A Virtual Journal Club Series for the Advanced Practice Multiple Sclerosis Clinician

Article Title Stabilization without Rituximab after Disease Activation in an Alemtuzumab-Treated Patient with Multiple Sclerosis and a Literature Overview To access the article please visit Release Date: November 30, 2019 Valid for Credit Through: November 30, 2020 Description Due to the complex challenges presented by multiple sclerosis, the ever-changing landscape of treatment options, and the […]

How Can We Apply Guidelines in the Rapidly Changing MS Treatment Landscape?

Credit TypesAAPA: 1.00ACPE: 1.00CME: 1.00CNE: 1.00CNE – Pharmacology: 1.00Letter of Completion: 1.00 Management of multiple sclerosis (MS) occurs in a rapidly changing environment in which decisions must be made using the latest available data and insights. This webinar serves as a review and update to the CMSC Practical Guidelines for the Selection of Disease-Modifying Therapies […]

CMSC Practical Guidelines for the Selection of Disease Modifying Therapies in MS

Introduction This guideline was developed by a group of multiple sclerosis (MS) specialists, convened by the Consortium of Multiple Sclerosis Centers (CMSC), to serve as an educational guide and concise summary of available data and professional recommendations on the selection of disease-modifying therapy (DMT) for MS. The group met in Chicago, IL, in 2018 at […]

The Science of MS Management: Current Mechanisms in MS Therapy – Which Ones—and Why?

Target Audience This activity has been designed to meet the educational needs of physicians, advanced practice clinicians, nursing professionals, pharmacists, and other members of the healthcare team who manage patients with multiple sclerosis (MS). Learning Objectives Upon completion of this educational activity, the participant should be able to: Explain basic mechanisms in approved MS DMTs […]